The role of the bone marrow in allergy and asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 3, 1996, Pages 141-148

  Denburg, J A ^a   Inman, M D ^a   Leber, B ^a   Sehmi, R ^a   O'Byrne, P M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Allergy; Asthma; Basophils; Cytokines; Eosinophils; Hemopoiesis; Inflammation; Progenitors

Indexed keywords

BUDESONIDE; CORTICOSTEROID; CYTOKINE; IMMUNOGLOBULIN E; RETINOIC ACID;

ALLERGIC RHINITIS; ALLERGY; ASTHMA; BASOPHIL; BONE MARROW; BONE MARROW TRANSPLANTATION; EOSINOPHIL; HEMATOPOIESIS; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029943311     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04578.x     Document Type: Review

References (109)

1. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984;133:157-65.
2. Fritsch G, Buchinger P, Printz D, et al. Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis. Blood 1993;81:2301-9.
3. Kato K, Radbruch A. Isolation and characterization of CD34+ hematopoietic stem cells from human peripheral blood by high-gradient magnetic cell sorting. Cytometry 1993;14:384-92.
4. Lansdorp PM, Sutherland HJ, Eaves CJ. Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow. J Exp Med 1990;172:363-6.
5. Huang E, Nocka K, Beier DR, et al. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 1990;63:225-33.
6. Williams DE, Eisenman J, Baird A, et al. Identification of a ligand for the c-kit proto-oncogene. Cell 1990;63:167-74.
7. Zsebo KM, Williams DA, Geissler EN, et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990;63:213-24.
8. Rosnet O, Schiff C, Pebusque M, et al. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 1993;82:1110-19.
9. Eaves CJ. Peripheral blood stem cells reach new heights. Blood 1993;82:1957-9.
10. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 1994;367:645-8.
11. Fink L, Molgaard HV, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood 1990;75:2417-26.
12. Nickoloff BJ. The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol 1991;127:523-9.
13. Schligemann RD, Rietreld FJR, Waal RMW, et al. Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab Invest 1990;62:690-6.
14. Miyajima A, Mui AL-F, Ogorochi T, Sakamaki K. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 1993; 82:1960-74.
15. van Leeuwen BH, Martinson ME, Webb GC, Young IG. Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood 1989;73:1142-8.
16. Majdic O, Stockl J, Pickl WF, et al. Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. Blood 1994;83:1226-34.
17. Berenson RJ, Andrews RG, Bensinger WI, et al. Antigen CD34-positive marrow cells engraft lethally irradiated baboons. J Clin Invest 1988;81:951-5.
18. Berenson RJ, Bensinger WI, Hill RS, et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991;77:1717-22.
19. Metcalfe D. Hematopoietic regulators: redundancy or subtlety? Blood 1993;82:3515-23.
20. Vadas MA, Lopez AF, Gamble JR, Elliot MJ. Role of colony-stimulating factors in leucocyte responses to inflammation and infection. Curr Opin Immunol 1991; 3:97-104.
21. Denburg JA. Cytokine-induced human basophil/mast cell growth and differentiation in vitro. Springer Semin Immunopathol 1990;12:401-14.
22. Denburg JA. Basophil and mast cell lineages in vitro and in vivo. Blood 1992;79:846-60.
23. Denburg JA, Dolovich J, Harnish D. Basophil mast cell and eosinophil growth and differentiation factors in human allergic disease. Clin Exp Allergy 1989;19:249-54.
24. Denburg JA, Richardson M, Telizyn S, Bienenstock J. Basophil/mast cell precursors in human peripheral blood. Blood 1983;61:775-80.
25. Denburg JA, Telizyn S, Belda A, Dolovich J, Bienenstock J. Increased numbers of circulating basophil progenitors in atopic patients. J Allergy Clin Immunol 1985;76:466-72.
26. Denburg JA, Telizyn S, Messner H, et al. Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Blood 1985;66:312-18.
27. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993;81:2844-53.
28. Clutterbuck EJ, Sanderson CJ. Human eosinophil hematopoiesis studied in vitro by means of murine eosinophil differentiation factor (IL-5): production of functionally active eosinophils from normal human bone marrow. Blood 1988;71:646-51.
29. Denburg JA, Silver JE, Abrams JS. Interleukin-5 is a human basophilopoietin: induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitors. Blood 1991;77:1462-8.
30. Sanderson CJ, Warren DJ, Strath M. Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in culture. J Exp Med 1985;162:60-74.
31. Valent P, Ashman LK, Hinterberger W, et al. Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 1989;73:1778-85.
32. -, colony forming cell [Abstract]. Blood 1993;82 Suppl:102a.
33. Galli SJ. Biology of disease. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990;62:5-33.
34. Irani AA, Craig SS, Nilsson G, Ishizaka T, Schwartz LB. Characterizations of human mast cells developed in vitro from fetal liver cells cocultured with murine 3T3 fibroblasts. Immunology 1992;77:136-43.
35. Irani AM, Nilsson G, Miettinen U, et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992;80:3009-21.
36. Jarboe DL, Huff TF. The mast cell-committed progenitor. II. W/Wv mice do not make mast cell-committed progenitors and S1/S1d fibroblasts do not support development of normal mast cell-committed progenitors. J Immunol 1989;142:2418-23.
37. Jarboe DL, Marshall JS, Randolph TR, Kukolja A, Huff TF. The mast cell-committed progenitor. I. Description of a cell capable of IL-3-independent proliferation and differentiation without contact with fibroblasts. J Immunol 1989;142:2405-17.
38. Furitsu T, Saito H, Dvorak AM, et al. Development of human mast cells in vitro. Proc Natl Acad Sci USA 1989;86:10039-43.
39. Ginsburg H, Lagunoff D. The in vitro differentiation of mast cells. Cultures of cells from immunized mouse lymph nodes and thoracic duct lymph on fibroblast monolayers. J Cell Biol 1967;35:685-97.
40. Kirshenbaum AS, Goff JP, Dreskin SC, Irani A-M, Schwartz LB, Metcalfe DD. IL-3-dependent growth of basophil-like and mast-like cells from human bone marrow. J Immunol 1989;142:2424-9.
41. + bone marrow progenitor cells. J Immunol 1991;146:1410-15.
42. Saito H, Hatake K, Dvorak AM, et al. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc Natl Acad Sci U S A 1988;85:2288-92.
43. Wang C, De Coteau J, Pinkerton PH, Reis MD. C-kit expression and response to kit-ligand by leukemic basophils from chronic myelogenous leukemia in basophilic transformation [Abstract]. Blood 1993;82 Suppl:230a.
44. Wong DA, Switzer J, Ohtoshi T, Delespesse G, Dolovich J, Denburg J. CD23 expression on HL-60 cells: evidence for both basophilic and monocytic differentiation [Abstract]. J Allergy Clin Immunol 1991;87:305.
45. Juhlin L, Michaelsson G. A new syndrome characterized by absence of eosinophils and basophils. Lancet 1977;1:1233-5.
46. Parkin JL, McKenna RW, Brunning RD. Philadelphia chromosome-positive blastic leukemia: ultrastructural and ultracytochemical evidence of basophil and mast cell differentiation. Br J Haematol 1982;52:663-77.
47. Soler J, O'Brien M, de Castro JT, et al. Blast crisis of chronic granulocytic leukemia with mast cell and basophil precursors. Am J Clin Pathol 1985;83:254-9.
48. Zucker-Franklin D. Ultrastructural evidence for the common origin of human mast cells and basophils. Blood 1980;56:534-40.
49. Ebi Y, Kasugai T, Seino Y, Onoue H, Kanemoto T, Kitamura Y. Mechanism of mast cell deficiency in mutant mice of mi/mi genotype: an analysis by co-culture of mast cells and fibroblasts. Blood 1990;75:1247-51.
50. Kasugai T, Okada M, Morimoto M, et al. Infection of Nippostrongylus brasiliensis induces normal increase of basophils in mast cell-deficient Ws/Ws rats with a small deletion at the kinase domain of c-kit. Blood 1993;81:2521-9.
51. s mast cell-deficient rats with a small deletion at tyrosine kinase domain of c-kit. Blood 1994;83:916-25.
52. Tsujimura T, Koshimizu U, Katoh H, et al. Mast cell number in the skin of heterozygotes reflects the molecular nature of c-kit mutation. Blood 1993;81:2530-8.
53. Kasugai T, Tei H, Okada M, et al. Infection with Nippostrongylus brasiliensis induces invasion of mast cell precursors from peripheral blood to small intestine. Blood 1995;85:1334-40.
54. Sorden SD, Castleman WL. Virus-induced increases in bronchiolar mast cells in brown Norway rats are associated with both local mast cell proliferation and increases in blood mast cell precursors. Lab Invest 1995; 73:197-204.
55. Denburg JA, Befus AD, Bienenstock J. Growth and differentiation in vitro of mast cells from mesenteric lymph nodes of Nippostrongylus brasiliensis-infected rats. Immunology 1980;41:195-202.
56. Guy-Grand D, Dy M, Luffau G, Vassalli P. Gut mucosal mast cells: origin, traffic and differentiation. J Exp Med 1984;160:12-28.
57. Otsuka H, Dolovich J, Befus AD, Bienenstock J, Denburg JA. Peripheral blood basophils, basophil progenitors, and nasal metachromatic cells in allergic rhinitis. Am Rev Respir Dis 1986;133:757-62.
58. Otsuka H, Dolovich J, Befus AD, Telizyn S, Bienenstock J, Denburg JA. Basophilic cell progenitors, nasal metachromatic cells, and peripheral blood basophils in ragweed-allergic patients. J Allergy Clin Immunol 1986;78:365-71.
59. Owen WF Jr, Rothenberg ME, Silberstein DS, et al. Regulation of human eosinophil viability, density and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 1987;166:129-41.
60. Gasson JC. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 1991;77: 1131-45.
61. Bradding P, Feather IH, Howarth PH, et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992;176:1381-6.
62. Desreumaux P, Janin A, Colombel JF, et al. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med 1992;175:293-6.
63. Finotto S, Ohno I, Marshall JS, et al. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994;153:2278-89.
64. Kita H, Ohnishi T, Okubo Y, Weiler D, Abrams JS, Gleich GJ. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med 1991;174: 745-8.
65. Moqbel R, Hamid Q, Ying S, et al. Expression of mRNA and immunoreactivity for the granulocyte macrophage colony-stimulating factor in activated human eosinophils. J Exp Med 1991;174:749-52.
66. Nonaka M, Nonaka R, Woolley K, et al. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in rivo and is released by peripheral blood eosinophils. J Immunol 1995; 155:3234-44.
67. Ohno I, Lea R, Finotto S, et al. Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis. Am J Respir Cell Mol Biol 1991;5:505-10.
68. Ohno I, Lea RG, Flanders KC, et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor β1 gene (TGFβ1). J Clin Invest 1992;89:1662-8.
69. Wong DTW, Weller PF, Galli SJ, et al. Human eosinophils express transforming growth factor α. J Exp Med 1990;172:673-81.
70. Kung TT, Stelts D, Zurcher JA, et al. Mechanisms of allergic pulmonary eosinophilia in the mouse. J Allergy Clin Immunol 1994;94:1217-24.
71. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 1994;144:321-8.
72. Wershil BK, Wang ZS, Gordon JR, Galli SJ. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest 1991;87:446-53.
73. Costa JJ, Demetri GD, Harrist TJ, et al. Recombinant human stem cell factor (rhSCF) induces cutaneous mast cell activation and hyperplasia, and hyperpigmentation in humans in vivo [Abstract]. J Allergy Clin Immunol 1994;93:225.
74. Matsuda H, Coughlin MD, Bienenstock J, Denburg JA. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci USA 1988;85:6508-12.
75. Tsuda T, Wong D, Dolovich J, Bienenstock J, Marshall J, Denburg JA. Synergistic effects of nerve growth factor and granulocyte-macrophage colony-stimulating factor on human basophilic cell differentiation. Blood 1991;77:971-9.
76. Denburg JA, Dolovich J, Marshall J, et al. Eosinophil differentiation and cytokine networks in allergic inflammation. In: Gleich GJ, Kay AB, editors. Eosinophils in allergy and inflammation. New York: Marcel Dekker, 1994:211-23.
77. Denburg JA, Woolley M, Leber B, Linden M. O'Byrne P. Basophil and eosinophil differentiation in allergic reactions. J Allergy Clin Immunol 1994;94:1135-41.
78. Leber B, Switzer J, Denburg JA. Retinoic acid modulation of induced basophil differentiation. 1996 (submitted).
79. Tsai S, Collins SJ. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci U S A 1993;90:7153-7.
80. Popken-Harris P, Thomas L, Oxvig C, et al. Biochemical properties, activities, and presence in biologic fluids of eosinophil granule major basic protein. J Allergy Clin Immunol 1994;94:1282-9.
81. Wong DA, Valent P, Bettelheim P, Switzer J, Denburg JA. Immunophenotypic analysis of HL-60 cells during basophilic differentiation. Int Arch Allergy Immunol 1996 (in press).
82. Boyce JA, Friend D, Matsumoto R, Austen KF, Owen WF. Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate. J Exp Med 1995;182:49-57.
83. Tanno Y, Bienenstock J, Richardson M, Lee TDG, Befus AD, Denburg JA. Reciprocal regulation of human basophil and eosinophil differentiation by separate T-cell-derived factors. Exp Hematol 1987;15:24-33.
84. Denburg JA, Howie K, Girgis-Gabardo A. Expression of granulocyte macrophage-colony stimulating factor (GM-CSF) during maturation of eosinophils and basophils [Abstract]. J Allergy Clin Immunol 1994;93:194.
85. Björkstén B, Gamrelidze A, Vanto T, Kjellman M. Seasonal variation of IgE synthesis in vitro by human peripheral blood mononuclear cells. Allergy 1990;45:572-6.
86. Choudry NB, Watson R, Denburg J, O'Byrne PM. Time course of circulating inflammatory cells and their progenitors after allergen inhalation in asthmatic subjects [Abstract]. Am Rev Respir Dis 1992;145:A35.
87. Gibson PG, Dolovich J, Girgis-Gabardo A, et al. The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils and their progenitors. Clin Exp Allergy 1990;20:661-8.
88. Gibson PG, Manning PJ, O'Byrne PM, et al. Allergen-induced asthmatic responses: relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors. Am Rev Respir Dis 1991;143:331-5.
89. Linden M, Svensson C, Andersson M, et al. Increased numbers of circulating leucocyte progenitors in patients with allergic rhinitis during natural allergen exposure [Abstract]. Am J Respir Crit Care Med 1994;149:A602.
90. Woolley MJ, Denburg JA, Ellis R, Dahlback M, O'Byrne PM. Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters. Am J Respir Cell Mol Biol 1994;11:600-6.
91. Inman MD, Ellis R, Wattie J, et al. Stimulation of canine bone marrow granulocyte progenitor growth by a serum factor present 24 hours after allergen inhalation [Abstract]. J Allergy Clin Immunol 1995;95:376.
92. Denburg JA, Dolovich J, Ohtoshi T, Cox G, Gauldie J, Jordana M. The microenvironmental differentiation hypothesis of airway inflammation. Am J Rhinol 1990;4:29-32.
93. Jordana M, Vancheri C, Ohtoshi T, et al. Hemopoietic function of the microenvironment in chronic airway inflammation. Agents Actions Suppl 1989;28:85-95.
94. Kim YK, Nakagawa N, Sulakvelidze I, Dolovich J, Denburg JA. Immunolocalization of stem cell factor in inflamed human nasal tissues [Abstract]. J Allergy Clin Immunol 1996;97:282.
95. Nakagawa N, Howie K, Switzer J, Marshall JS, Denburg JA. Human nasal polyp fibroblasts produce stem cell factor (SCF) [Abstract]. J Allergy Clin Immunol 1995;95:292.
96. Ohnishi M, Ruhno J, Bienenstock J, Dolovich J, Denburg JA. Hematopoietic growth factor production by cultured cells of human nasal polyp epithelial scrapings: kinetics, cell source, and relationship to clinical status. J Allergy Clin Immunol 1989;83:1091-1100.
97. Ohtoshi T, Tsuda T, Vancheri C, et al. Human upper airway epithelial cell-derived granulocyte-macrophage colony-stimulating factor induces histamine-containing cell differentiation of human progenitor cells. Int Arch Allergy Appl Immunol 1991;95:376-84.
98. Gautam SC, Pindolia KR, Noth CJ, Janakiraman N, Xu YX, Chapman RA. Chemokine gene expression in bone marrow stromal cells: downregulation with sodium salicylate. Blood 1995;86:2541-50.
99. Gewirtz AM, Zhang J, Ratajczak J, et al. Chemokine regulation of human megakaryocytopoiesis. Blood 1995;86:2559-67.
100. Costa JJ, Matossian K, Resnick MB, et al. Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest 1993;91:2673-84.
101. Roodman GD. TNF and hematopoiesis. In: Beutler B, editor. Tumor necrosis factors: the molecules and their emerging role in medicine. New York: Raven Press, 1992:117-29.
102. Sillaber C, Geissler K, Scherrer R, et al. Type beta transforming growth factors promote interleukin-3 (IL-3)-dependent differentiation of human basophils but inhibit IL-3-dependent differentiation of human eosinophils. Blood 1992;80:634-41.
103. Wahl SM. Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure. J Clin Immunol 1992;12:61-74.
104. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501-7.
105. Corris PA, Dark JH. Aetiology of asthma: lessons from lung transplantation. Lancet 1993;341:1369-71.
106. + hemopoietic progenitor cells in atopic subjects. Am J Respir Cell Mol Biol 1996 (in press).
107. Sehmi R, Wood L, Watson R, Inman MD, O'Byrne PM. Denburg JA. Increases in circulating CD34+ hemopoietic progenitors in allergen-induced late asthmatic responses [Abstract]. J Allergy Clin Immunol 1996;97:277.
108. Sehmi R, Wood LJ, Inman MD, et al. Increases in bone marrow derived CD34+ hemopoietic progenitor cells expressing the alpha-subunit of IL-3 receptors following allergen challenge in mild asthmatics [Abstract]. Am Rev Respir Dis 1996 (in press).
109. Agosti JM, Sprenger JD, Lum LG, et al. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med 1988;319:1623-8.